Rheumatology
From the Journals
Late-Onset Axial Spondyloarthritis: How Does It Differ From Early-Onset Disease?
Late-onset axSpA may represent “a distinct phenotype with a weaker association with HLA-B27.”
From the Journals
Onset of Rheumatoid Arthritis Presaged by Changes in Gut Microbiome
Alterations in the gut microbiome began as early as 10 months before the onset of RA in anti–cyclic citrullinated protein–positive individuals at...
Latest News
Scurvy: A Diagnosis Still Relevant Today
Scurvy can cause mucosal and gastric hemorrhages, and may be linked to poor diet or bariatric surgery.
Feature
RA Prevention: A Decade of Trials Provides Insights on What’s to Come
Data from recent studies suggested improved risk stratification and understanding of disease pathogenesis are key in identifying more effective...
Latest News
Novel Treatment Promising for Cutaneous Lupus in Phase 2 Trial
Iberdomide is a cereblon modulator, which results in degradation of two transcription factors of immune cell development and homeostasis...
Feature
What’s the Evidence Behind Popular Supplements in Rheumatology? Experts Weigh in
Many people with rheumatologic diseases try supplements for symptom relief. Here’s what you need to know about some common picks.
From the Journals
Cannabis Often Used as a Substitute for Traditional Medications
A recent cross-sectional survey showed that a considerable number of patients with rheumatic diseases switched to medical cannabis for better...
From the Journals
Total Hip Replacement Superior to Exercise Therapy for Improving Hip Osteoarthritis Pain and Function
Greater improvement in patient-reported hip pain and function at 6 months was achieved with total hip replacement than with resistance training in...
From the Journals
Extended-Release Fluticasone Injection Successful in Phase 2 Knee OA Trial
The long-acting formulation of fluticasone propionate utilizing extended-release technology may offer a longer duration of pain relief than...
Feature
Therapeutic Drug Monitoring in Rheumatology: A Promising Outlook But Many Barriers to Overcome
Tracking patient response to DMARD therapy has the potential to improve remission, but multiple barriers must be overcome before it’s widely...
From the Journals
Few Differences Seen in RA Pain Outcomes for JAK Inhibitors, Biologics
JAK inhibitors were found to be either marginally more effective or as effective as biologic DMARDs in reducing pain in patients with rheumatoid...